W ith the advent of tissue regeneration and gene therapy for heart disease, evaluation of coronary circulation and cardiac function in vivo, especially in a disease model, is extremely important. Conventional methods such as microcomputed tomography, high-resolution magnetic resonance angiography, and high-resolution ultrasound have become invaluable tools in cardiovascular research. However, the disadvantages and limitations of these approaches sometimes preclude researchers from conducting important and specific studies on coronary circulation and cardiac function. Therefore, we developed and applied a novel real-time, in vivo fluorescent optical imaging system for use in the mouse cardiovascular system. We report the use of this system for repeatedly assessing coronary circulation, cardiovascular structure, and cardiac function in live mice.
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First, we evaluated whether our new system can detect coronary vasodilator responses and changes in cardiac wall motion. Anesthesia was induced in C57BL/6 mice by 3.0% sevoflurane inhalation, and the heart was exposed through a left thoracotomy. One hundred microliters of an optical imaging probe (AngioSense-IVM 680, VisEn Medical Inc, Woburn, Mass), which has an excitation wavelength of 680 nm and an emission fluorescence wavelength of 700 nm, was injected through a cannula (Micro-Cannula, BioTime Inc, Berkeley, Calif) inserted in the femoral vein. Cardiovascular imaging was performed using the Olympus OV110 imaging system (Olympus Corp, Tokyo, Japan) (Figure 1A through 1D; Movie IA and IB). After obtaining video records of cardiovascular responses and cardiac motion at a frame rate of 7 frames per second, we infused nitroglycerin (Millisrol) into the femoral vein with a syringe pump at a flow rate of 25 L/min. The vasodilator effect of nitroglycerin on the left anterior descending coronary artery (LAD) was clearly visible as exaggerated cardiac motion due to decreased preload with our system ( Figure 1E ; Movie IC). We captured the images of a widely dilated LAD in these videos and estimated the relative alteration of vasodilation using Image J (National Institutes of Health, Bethesda, Md) ( Figure 1F ). In addition, we evaluated whether this system can record the changes in myocardial ischemia and reperfusion in live mice. Using the myocardial ischemia and reperfusion model developed by Michael et al, 1 we observed the blocked blood flow and reperfusion of the LAD with cardiac motion using our system (Figure 2 ; Movie II). Moreover, we examined whether the level of myocardial infarction (MI) was predictable without preparation of tissue samples. After a complete LAD ligation, we verified its success using our system, by ST-segment elevation in the ECG, and visually by the color change of the ischemic area ( Figure 3A and 3B) . Two weeks after operating MI, we observed blood stasis in the left ventricular (LV) cavity ( Figure 3C and 3D) . The findings obtained for the fluorescence images of blood stasis were identical to those observed in the Masson trichrome-stained LV cavity ( Figure  3E and 3F), which implies that this optical imaging system can evaluate cardiac function in live mice even with MI. For each experiment, we used 2 optical imaging probes (AngioSense-IVM 680 and AngioSense-IVM 750) of different wavelengths. Since we could observe different parts of tissues depending on the different wavelengths, we used separate probes as the situation demanded. This system could be a powerful tool for studying coronary circulation and cardiac function.
Disclosures
None. we took 3 points on the LAD and measured the average pixel density of these points using Image J. The relative alteration of vasodilation was calculated that the numerical value of average pixel density after injecting nitroglycerin were divided by the numerical value of that before injecting (relative alteration of vasodilation = numerical value of average pixel density after injecting nitroglycerin/numerical value of average pixel density before injecting nitroglycerin).
